Gilead Sciences is a US biotechnology company. Its focus is drugs for HIV, hepatitis B and C and cancer therapies, including cell therapies. Well-known products include the HIV drug Biktarvy and the Covid drug Veklury. As of Oct 11, 2026
The biopharmaceutical company, based in Foster City, offers medicines for HIV, viral hepatitis, COVID and cancer. For HIV it markets Biktarvy and Descovy, among others. In liver disease it markets Epclusa for chronic hepatitis C, also as an authorized generic through a subsidiary. In oncology it offers a cell therapy for certain forms of lymphoma and leukemia and an antibody-drug conjugate for certain forms of breast cancer. In the US market, sales and distribution of most products run exclusively through wholesalers, mainly Cardinal Health, Cencora and McKesson. Outside the US market it sells through its own teams, external distributors or partners, and manufacturing is in part done by contract manufacturers.
Automatically summarized from SEC annual report (10-K, filed Feb 24, 2026) (website of the US Securities and Exchange Commission) · reviewed Oct 14, 2026
Our own calculation from the exchange’s daily candles, as of Oct 27, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.
Still above the buy zone
After a rise there is a buy zone; the price is still above it. “Near the buy zone” (from Watcher) shows how close it is.
As of: Close of the 4-hour candle Oct 27, 2026, 18:30 · Buy zone in the trade plan · An observation, not investment advice
Rule (4-hour candles) Zone valid since Oct 19, 2026 · last changed on Oct 21, 2026 Zone historyThe zone history shows since when a buy zone has applied, when it was adjusted and when the price touched or left it. Recording began on Oct 12, 2026, only runs forward and fills nothing in – older zones are marked “known at start of recording” or “already existing when added”.Example: New buy zone on Oct 14, no adjustment since → “zone valid since Oct 14, 2026 · unchanged since”.More in the Academy: Lesson buy zone and Fibonacci
Watcher Full history: every change of the buy zone with its date.
Weekly candles (1W) No active buy zone – the last one ended in the Week from Oct 12, 2026 · Buy zone no longer valid Zone historyThe zone history shows since when a buy zone has applied, when it was adjusted and when the price touched or left it. Recording began on Oct 12, 2026, only runs forward and fills nothing in – older zones are marked “known at start of recording” or “already existing when added”.Example: New buy zone on Oct 14, no adjustment since → “zone valid since Oct 14, 2026 · unchanged since”.More in the Academy: Lesson buy zone and Fibonacci
Watcher Full history: every change of the buy zone with its date.
Timeframe 1 week · As of Oct 23, 2026 · display only, the rule works on 4-hour candles
Elliott count: Double zigzag (W-X-Y), Corrective pattern (upward), Y in progress (3 of 3 guidelines) · X = 70% of W; Y = 75% of W
Alternative (not drawn): Combination (W-X-Y-X-Z), Corrective pattern (upward), Z in progress (3 of 3 guidelines)
Note: Structure ambiguous: leg X can also be read as three- or five-part.
Note: Retracement at least 88.7% of A: flat possible (B in progress, type only with C).
Elliott count calculated automatically by fixed Elliott rules, not investment advice – display only, our buy zones do not use it. Provisional: The count can change with new candles.
No buy zone of the rule on this timeframe – the chart shows only the Elliott count from the completed weekly candles (recalculated every day). Not a recommendation, not investment advice. Without a buy zone there is no reference for percentages – so no value axis and no prices; measurements are ratios of wave lengths.
Timeframe 1 day · As of Oct 27, 2026 · display only, the rule works on 4-hour candles
Elliott count: Zigzag (A-B-C), Corrective pattern (upward), C in progress (3 of 3 guidelines) · B = 44% of A; C = 67% of A
Alternative (not drawn): Combination (W-X-Y), Corrective pattern (upward), Y in progress (3 of 3 guidelines)
Note: Structure ambiguous: leg A can also be read as three- or five-part.
Note: Retracement at least 88.7% of A: flat possible (B in progress, type only with C).
Elliott count calculated automatically by fixed Elliott rules, not investment advice – display only, our buy zones do not use it. Provisional: The count can change with new candles.
No buy zone of the rule on this timeframe – the chart shows only the Elliott count from the completed daily candles (recalculated every day). Not a recommendation, not investment advice. Without a buy zone there is no reference for percentages – so no value axis and no prices; measurements are ratios of wave lengths.
Timeframe 4 hours · As of Oct 27, 2026
Elliott count: no count that follows the rules on this timeframe.
Elliott count calculated automatically by fixed Elliott rules, not investment advice – display only, our buy zones do not use it. Provisional: The count can change with new candles.
Automated analysis (rule-based): the rule calculates waves and Fibonacci levels from the completed 4-hour candles; the chart is recalculated every hour. Not investment advice. Axis and values: distance from the top of the buy zone in %, no prices.
On phones the drawing toolbar is hidden – drawing works better on a desktop.
Timeframe 1 hour · As of Oct 27, 2026 · display only, the rule works on 4-hour candles
Elliott count: no count that follows the rules on this timeframe.
Elliott count calculated automatically by fixed Elliott rules, not investment advice – display only, our buy zones do not use it. Provisional: The count can change with new candles.
Automated analysis (rule-based): the rule calculates waves and Fibonacci levels from the completed hourly candles; the chart is recalculated every hour. Not investment advice. On this timeframe the chart only shows the rule setup (swing detection 4 × ATR) – the rule itself works on 4-hour candles. Axis and values: distance from the top of the buy zone in %, no prices.
On phones the drawing toolbar is hidden – drawing works better on a desktop.
Timeframe 1 week · As of Oct 23, 2026 · from the Elliott count in the analysis chart
Weighting Main scenario and alternative: level (3 of 3 guidelines each, strong) – the simpler or clearer pattern counts as the main scenario. Guidelines (strength of the count)Guidelines are typical features of a count, such as usual Fibonacci lengths or a change in the form of correction. Strong means: at least three quarters met, medium: at least half, otherwise weak. Even a strong count can flip.Example: 3 of 3 guidelines → strong; 2 of 4 → medium; 1 of 3 → weak.More in the Academy: Lesson wave degrees
Weighting by guidelines met – not a probability.
As long as the weekly close stays above the end of X, this applies: complex countermove upward (Double zigzag W-X-Y), Y in progress – count points to rising prices.
Invalid if the weekly close is below the end of X
If that breaks, the second reading no longer applies either: complex countermove upward (Combination W-X-Y-X-Z), Z in progress – then there is no valid count for now; the next candles will produce a new one.
Invalid if the weekly close is below the end of the second X
Watcher Fibonacci target zones and levels for this count – as a help for your own review – from Watcher.
Timeframe 1 day · As of Oct 27, 2026 · from the Elliott count in the analysis chart
Weighting Main scenario and alternative: level (3 of 3 guidelines each, strong) – the simpler or clearer pattern counts as the main scenario. Guidelines (strength of the count)Guidelines are typical features of a count, such as usual Fibonacci lengths or a change in the form of correction. Strong means: at least three quarters met, medium: at least half, otherwise weak. Even a strong count can flip.Example: 3 of 3 guidelines → strong; 2 of 4 → medium; 1 of 3 → weak.More in the Academy: Lesson wave degrees
Weighting by guidelines met – not a probability.
As long as the daily close stays above the end of B, this applies: sharp countermove upward in three waves (Zigzag A-B-C), C in progress – count points to rising prices.
Invalid if the daily close is below the end of B
If that breaks, the second reading no longer applies either: complex countermove upward (Combination W-X-Y), Y in progress – then there is no valid count for now; the next candles will produce a new one.
Invalid if the daily close is below the end of X
Watcher Fibonacci target zones and levels for this count – as a help for your own review – from Watcher.
Timeframe 4 hours · As of Oct 27, 2026 · from the Elliott count in the analysis chart
Weighting by guidelines met – not a probability.
Currently no wave count that follows the rules on 4-hour candles – so no scenarios.
Timeframe 1 hour · As of Oct 27, 2026 · from the Elliott count in the analysis chart
Weighting by guidelines met – not a probability.
Currently no wave count that follows the rules on hourly candles – so no scenarios.
The price is still above the buy zone (0 to −2.0% from its top) (61.8–78.6% of the wave 1 rise). Rule trigger: the daily low reaches the zone, then a swing high forms and a daily close is above it. Whether the price reaches the zone is open – if it rises above the wave 1 high first, the setup is void. All percentages: distance from the top of the buy zone.
In the TradingView chart: Draw the buy zone in the chart with the Fibonacci tool (instructions next to the wave chart) or as two horizontal lines (tool “Horizontal Line”). If the price closes below the start of wave 1 (−4.6%), the setup is void – without an entry of the rule.
Exit with a gain
Buy zone – Rule trigger: candle close above the swing high
Exit at a loss
Watcher Target 1, Target 2 and stop for this zone – with distance in percent and reward/risk – are available from Watcher. Plans and pricing Percentages from the top of the buy zone (61.8%) – not a forecast.
Rule-based, long only, 4-hour candles. Not a forecast and not investment advice. Lesson: the buy zone in 4 minutes
Gilead Sciences · Sector Health Care · amounts in USD
Information only – does not affect our buy zones, not investment advice. Source: SEC filings, As of Feb 24, 2026.
Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.
Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 29.4B USD · Net income 8.5B USD · Net margin 28.9%
Each light follows a simple, disclosed rule. The comparison is with the sector median Sector medianThe middle value of all companies in a sector: half are above it, half below. Unlike the average, single outliers hardly distort it.Example: Margins 4%, 8%, 10%, 12%, 60% → median 10%, average 18.8%.More in the Academy: Lesson putting the P/E in context of all 63 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).
+3.6% per year, last 5 years
Sector Health Care: median +7.8% (60 symbols)
What does this mean? Revenue: over 5 years it grew by 3.6% per year on average, but more slowly than the median company in the sector (+7.8%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
+133.3% per year, last 5 years
Sector Health Care: median +7.5% (46 symbols)
per share: +132.4% per year (5 years, split-adjusted)
What does this mean? Total net income: over 5 years it grew by 133.3% per year on average – at least as fast as the median company in the sector (+7.5%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
28.9% last fiscal year
Sector Health Care: median 12.9% (63 symbols)
What does this mean? Of every 100 USD in revenue, 28.90 USD remained as profit – at least as much as the median company in the sector (12.9%). Five years ago the margin was 0.5%.
Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.
2.22 latest balance sheet
Sector Health Care: median 0.66 (40 symbols)
What does this mean? For every 1 USD of equity there is 2.22 USD of financial debt – more than twice as much as the median company in the sector (0.66). More debt amplifies good and bad years alike.
Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.
47% Dividend / earnings per share
Sector Health Care: median 28% (31 symbols)
What does this mean? Of every 1 USD of earnings per share, 0.47 USD went to shareholders as a dividend. The rest stays in the company. Median company in the sector: 28%.
Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.
10 of 10 fiscal years with a profit
What does this mean? In 10 of the last 10 fiscal years the bottom line showed a profit. There were no losses in this period.
Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).
| Year | End | Revenue | Net income | Margin | Earnings per share | Dividend per share | Payout |
|---|---|---|---|---|---|---|---|
| 2025 | Dec 31, 2025 | 29.4B | 8.5B | 28.9% | 6.78 | 3.16 | 47% |
| 2024 | Dec 31, 2024 | 28.8B | 480.0M | 1.7% | 0.38 | 3.08 | 811% |
| 2023 | Dec 31, 2023 | 27.1B | 5.7B | 20.9% | 4.50 | 3.00 | 67% |
| 2022 | Dec 31, 2022 | 27.3B | 4.6B | 16.8% | 3.64 | 2.92 | 80% |
| 2021 | Dec 31, 2021 | 27.3B | 6.2B | 22.8% | 4.93 | 2.84 | 58% |
| 2020 | Dec 31, 2020 | 24.7B | 123.0M | 0.5% | 0.10 | 2.72 | 2,720% |
| 2019 | Dec 31, 2019 | 22.4B | 5.4B | 24.0% | 4.22 | 2.52 | 60% |
| 2018 | Dec 31, 2018 | 22.1B | 5.5B | 24.7% | 4.17 | 2.28 | 55% |
| 2017 | Dec 31, 2017 | 26.1B | 4.6B | 17.7% | 3.51 | 2.08 | 59% |
| 2016 | Dec 31, 2016 | 30.4B | 13.5B | 44.4% | 9.94 | 1.84 | 19% |
| Quarter | End | Revenue | Net income | Margin | Earnings per share | Dividend per share | Payout |
|---|---|---|---|---|---|---|---|
| Q2/26 | Jun 30, 2026 | 7.8B | −10.5B | −134.5% | −8.45 | 0.82 | – |
| Q1/26 | Mar 31, 2026 | 7.0B | 2.0B | 29.0% | 1.61 | 0.82 | 51% |
| Q4/25* | Dec 31, 2025 | 7.9B | 2.2B | 27.5% | – | 0.79 | – |
| Q3/25 | Sep 30, 2025 | 7.8B | 3.1B | 39.3% | 2.43 | 0.79 | 33% |
| Q2/25 | Jun 30, 2025 | 7.1B | 2.0B | 27.7% | 1.56 | 0.79 | 51% |
| Q1/25 | Mar 31, 2025 | 6.7B | 1.3B | 19.7% | 1.04 | 0.79 | 76% |
| Q4/24* | Dec 31, 2024 | 7.6B | 1.8B | 23.6% | – | 0.77 | – |
| Q3/24 | Sep 30, 2024 | 7.5B | 1.3B | 16.6% | 1.00 | 0.77 | 77% |
| Q2/24 | Jun 30, 2024 | 7.0B | 1.6B | 23.2% | 1.29 | 0.77 | 60% |
| Q1/24 | Mar 31, 2024 | 6.7B | −4.2B | −62.4% | −3.34 | 0.77 | – |
| Q4/23* | Dec 31, 2023 | 7.1B | 1.4B | 20.1% | – | 0.75 | – |
| Q3/23 | Sep 30, 2023 | 7.1B | 2.2B | 30.9% | 1.73 | 0.75 | 43% |
* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.
How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.
| Period | Purchases | Sales | Net |
|---|---|---|---|
| 3 months | $00 people | $15.9M5 people | −$15.9M |
| 6 months | $00 people | $26.6M5 people | −$26.6M |
| 12 months | $00 people | $87.9M7 people | −$87.9M |
Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.
ATR ATR (Average True Range)The average range per trading day over the last 14 days. It makes distances comparable, whether a stock costs 10 or 1,000.Example: ATR 2.50 at a price of 100: 0.4 ATR is 1.00, i.e. 1%.More in the Academy: Lesson ATR and moving averages as price values only when logged in.
Latest news
No posts on GILD yet – log in to join the discussion.
Posts are opinions of users and only visible after logging in. Community rules